Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses.

COH-FIT Covid-19 P-factor Psychiatry Survey Well-being

Journal

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
ISSN: 1873-7862
Titre abrégé: Eur Neuropsychopharmacol
Pays: Netherlands
ID NLM: 9111390

Informations de publication

Date de publication:
27 Sep 2024
Historique:
received: 28 05 2024
revised: 17 07 2024
accepted: 21 07 2024
medline: 29 9 2024
pubmed: 29 9 2024
entrez: 28 9 2024
Statut: aheadofprint

Résumé

There is no multi-country/multi-language study testing a-priori multivariable associations between non-modifiable/modifiable factors and validated wellbeing/multidimensional mental health outcomes before/during the COVID-19 pandemic. Moreover, studies during COVID-19 pandemic generally do not report on representative/weighted non-probability samples. The Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) is a multi-country/multi-language survey conducting multivariable/LASSO-regularized regression models and network analyses to identify modifiable/non-modifiable factors associated with wellbeing (WHO-5)/composite psychopathology (P-score) change. It enrolled general population-representative/weighted-non-probability samples (26/04/2020-19/06/2022). Participants included 121,066 adults (age=42±15.9 years, females=64 %, representative sample=29 %) WHO-5/P-score worsened (SMD=0.53/SMD=0.74), especially initially during the pandemic. We identified 15 modifiable/nine non-modifiable risk and 13 modifiable/three non-modifiable protective factors for WHO-5, 16 modifiable/11 non-modifiable risk and 10 modifiable/six non-modifiable protective factors for P-score. The 12 shared risk/protective factors with highest centrality (network-analysis) were, for non-modifiable factors, country income, ethnicity, age, gender, education, mental disorder history, COVID-19-related restrictions, urbanicity, physical disorder history, household room numbers and green space, and socioeconomic status. For modifiable factors, we identified medications, learning, internet, pet-ownership, working and religion as coping strategies, plus pre-pandemic levels of stress, fear, TV, social media or reading time, and COVID-19 information. In multivariable models, for WHO-5, additional non-modifiable factors with |B|>1 were income loss, COVID-19 deaths. For modifiable factors we identified pre-pandemic levels of social functioning, hobbies, frustration and loneliness, and social interactions as coping strategy. For P-scores, additional non-modifiable/modifiable factors were income loss, pre-pandemic infection fear, and social interactions as coping strategy. COH-FIT identified vulnerable sub-populations and actionable individual/environmental factors to protect well-being/mental health during crisis times. Results inform public health policies, and clinical practice.

Identifiants

pubmed: 39341043
pii: S0924-977X(24)00186-X
doi: 10.1016/j.euroneuro.2024.07.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-15

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Conflict of interest Conflict of interest statements of all authors are detailed in eTable 12.

Auteurs

Marco Solmi (M)

University of Ottawa, Department of Psychiatry, Ontario, Canada; The Ottawa Hospital, Department of Mental Health, Ontario, Canada; Ottawa Hospital Research Institute (OHRI) Neurosciences Program, Ottawa Ontario, Canada; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; Centre for Innovation in Mental Health-Developmental Lab, School of Psychology, University of Southampton, and NHS Trust, Southampton, United Kingdom; Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.

Trevor Thompson (T)

Centre for Chronic Illness and Ageing, University of Greenwich, London, United Kingdom.

Samuele Cortese (S)

University of Southampton, Centre for Innovation in Mental Health, Southampton, United Kingdom.

Andrés Estradé (A)

Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; Universidad Católica, Department of Psychology, Montevideo, Uruguay.

Agorastos Agorastos (A)

Aristotle University of Thessaloniki, II. Dept. of Psychiatry, Division of Neurosciences, Medical School, Faculty of Health Sciences, Greece.

Joaquim Radua (J)

Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Imaging of Mood- and Anxiety-Related Disorders (IMARD), University of Barcelona, CIBERSAM, Instituto de Salud Carlos III, Barcelona, Spain; Karolinska Institutet, Centre for Psychiatric Research and Education, Department of Clinical Neuroscience, Stockholm, Sweden.

Elena Dragioti (E)

Linköping University, Pain and Rehabilitation Centre and Department of Health, Medicine and Caring Sciences, Linköping, Sweden; University of Ioannina, Research Laboratory Psychology of Patients, Families & Health Professionals, Department of Nursing, School of Health Sciences, Ioannina, Greece.

Davy Vancampfort (D)

Katholieke Universiteit Leuven (KU Leuven), Department of Rehabilitation Sciences, Leuven, Belgium.

Lau Caspar Thygesen (LC)

National Institute of Public Health, University of Southern Denmark, Denmark.

Harald Aschauer (H)

BioPsyC - Biopsychosocial Corporation, Non-profit association for Research Funding Ltd., Vienna, Austria.

Monika Schlögelhofer (M)

BioPsyC - Biopsychosocial Corporation, Non-profit association for Research Funding Ltd., Vienna, Austria.

Elena Aschauer (E)

BioPsyC - Biopsychosocial Corporation, Non-profit association for Research Funding Ltd., Vienna, Austria.

Andres Schneeberger (A)

University of California San Diego, California, United States.

Christian G Huber (CG)

University of Basel, Universitäre Psychiatrische Kliniken Basel (UPK), Basel, Switzerland.

Gregor Hasler (G)

University of Fribourg, Fribourg Network of Mental Health (RFSM), Fribourg, Switzerland.

Philippe Conus (P)

University of Lausanne, Department of Psychiatry, Lausanne, Switzerland.

Kim Q Do Cuénod (KQD)

University of Lausanne, Department of Psychiatry, Lausanne, Switzerland.

Roland von Känel (R)

University of Zurich, University Hospital Zurich, Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, Switzerland.

Gonzalo Arrondo (G)

Karolinska Institutet, Centre for Psychiatric Research and Education, Department of Clinical Neuroscience, Stockholm, Sweden; University of Navarra, Mind-Brain Group, Institute for Culture and Society (ICS), Pamplona, Spain.

Paolo Fusar-Poli (P)

Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; OASIS service, South London and Maudsley NHS Foundation Trust, London, United Kingdom; University of Pavia, Department of Brain and Behavioral Sciences, Pavia, Italy.

Philip Gorwood (P)

Université Paris Cité, CMME, GHU Paris Psychiatrie et Neurosciences, Paris, France; Institute de Psychiatrie et Neuroscience de Paris, INSERM U1266, F-75014, Paris, France.

Pierre-Michel Llorca (PM)

Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Psychiatrie B, Clermont-Ferrand, France.

Marie-Odile Krebs (MO)

Institute de Psychiatrie et Neuroscience de Paris, INSERM U1266, F-75014, Paris, France; Université de Paris, PEPIT, GHU Paris Psychiatrie et Neuroscience, Paris, France.

Elisabetta Scanferla (E)

Université Paris Cité, CMME, GHU Paris Psychiatrie et Neurosciences, Paris, France.

Taishiro Kishimoto (T)

Keio University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan.

Golam Rabbani (G)

The National Foundation of Mental Health of Bangladesh, Bangladesh.

Karolina Skonieczna-Żydecka (K)

Pomeranian Medical University in Szczecin, Department of Biochemical Sciences, Szczecin, Poland.

Paolo Brambilla (P)

University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Neurosciences and Mental Health, Milan, Italy.

Angela Favaro (A)

University of Padua, Neurosciences Department, Padua, Italy.

Akihiro Takamiya (A)

Keio University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan.

Leonardo Zoccante (L)

UOC Infanzia, Adolescenza, Famiglia e Consultori, Districts 1 & 2 AULSS 9 Scaligera, Verona, Italy.

Marco Colizzi (M)

University of Udine, Department of Medicine (DAME), Unit of Psychiatry, Italy.

Julie Bourgin (J)

Service de Psychiatrie de l'enfant et de l'adolescent, GHNE, 91440 Bures Sur Yvette, France.

Karol Kamiński (K)

Medical University of Białystok, Department of Population Medicine and Lifestyle Diseases Prevention, Bialystok, Poland.

Maryam Moghadasin (M)

Kharazmi University, Department of Clinical Psychology, Faculty of Psychology and Education, Tehran, Iran.

Soraya Seedat (S)

South African Medical Research Council Unit on the Genomics of Brain Disorders, Stellenbosch University, Department of Psychiatry, Faculty of Medicine and Health Sciences, South Africa.

Evan Matthews (E)

South East Technological University, School of Health Science, Waterford, Ireland.

John Wells (J)

South East Technological University, School of Health Science, Waterford, Ireland.

Emilia Vassilopoulou (E)

University of Nicosia, Department of Life and Health Sciences, Nicosia, Cyprus.

Ary Gadelha (A)

Universidade Federal de São Paulo, Department of Psychiatry, São Paulo, Brazil.

Kuan-Pin Su (KP)

An-Nan Hospital, China Medical University, Department of Psychiatry, Tainan, Taiwan; China Medical University Hospital, Mind-Body Interface Research Center, Taichung, Taiwan.

Jun Soo Kwon (JS)

Seoul National University College of Medicine, Department of Psychiatry, Seoul, Republic of Korea.

Minah Kim (M)

Seoul National University Hospital, Department of Neuropsychiatry, Seoul, Republic of Korea.

Tae Young Lee (TY)

Pusan National University Yangsan Hospital, Department of Psychiatry, Yangsan, Republic of Korea.

Oleg Papsuev (O)

University of Ottawa, Department of Psychiatry, Ontario, Canada; The Ottawa Hospital, Department of Mental Health, Ontario, Canada; Ottawa Hospital Research Institute (OHRI) Neurosciences Program, Ottawa Ontario, Canada.

Denisa Manková (D)

National Institute of Mental Health, Klecany, Czech Republic.

Andrea Boscutti (A)

UTHealth Houston, Department of Psychiatrys, USA.

Cristiano Gerunda (C)

University of Padua, Neurosciences Department, Padua, Italy.

Diego Saccon (D)

AULSS4 Veneto Orientale, Addictions Department, Italy.

Elena Righi (E)

University of Modena and Reggio Emilia, Department of Biomedical, Metabolic and Neural Sciences, Modena, Italy.

Francesco Monaco (F)

ASL Salerno, Department of Mental Health, Salerno, Italy; European Biomedical Research Institute of Salerno (EBRIS), Salerno, Italy.

Giovanni Croatto (G)

University of Padova, Padova, Italy.

Guido Cereda (G)

University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy.

Jacopo Demurtas (J)

University of Modena and Reggio Emilia, Clinical and Experimental Medicine PhD Program, Modena, Italy.

Natascia Brondino (N)

University of Pavia, Department of Brain and Behavioral Sciences, Pavia, Italy.

Nicola Veronese (N)

University of Palermo, Department of Internal Medicine, Geriatrics Section, Palermo, Italy.

Paolo Enrico (P)

University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy.

Pierluigi Politi (P)

University of Pavia, Department of Brain and Behavioral Sciences, Pavia, Italy.

Valentina Ciappolino (V)

Unit of Psychiatry, Azienda Ospedaliero-Universitaria Ss. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.

Andrea Pfennig (A)

Technische Universität Dresden, University Hospital Carl Gustav Carus, Department of Psychiatry and Psychotherapy, Dresden, Germany.

Andreas Bechdolf (A)

Charité Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Berlin, Germany.

Andreas Meyer-Lindenberg (A)

Heidelberg University, Central Institute of Mental Health, Medical Faculty Mannheim, Germany.

Kai G Kahl (KG)

Hannover Medical School, Department of Psychiatry, Social Psychiatry and Psychotherapy, Germany.

Katharina Domschke (K)

University of Freiburg, Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.

Michael Bauer (M)

Technische Universität Dresden, University Hospital Carl Gustav Carus, Department of Psychiatry and Psychotherapy, Dresden, Germany.

Nikolaos Koutsouleris (N)

Ludwig-Maximilians-University of Munich, Munich, Germany.

Sibylle Winter (S)

Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.

Stefan Borgwardt (S)

Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.

Istvan Bitter (I)

Semmelweis University, Department of Psychiatry and Psychotherapy, Budapest, Hungary.

Judit Balazs (J)

Eotvos Lorand University, Institute of Psychology, Budapest, Hungary; Bjørknes University College, Oslo, Norway.

Pál Czobor (P)

Semmelweis University, Department of Psychiatry and Psychotherapy, Budapest, Hungary.

Zsolt Unoka (Z)

Semmelweis University, Department of Psychiatry and Psychotherapy, Budapest, Hungary.

Dimitris Mavridis (D)

University of Ioannina, Department of Primary Education, Ioannina, Greece.

Konstantinos Tsamakis (K)

King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.

Vasilios P Bozikas (VP)

Aristotle University of Thessaloniki, II. Dept. of Psychiatry, Division of Neurosciences, Medical School, Faculty of Health Sciences, Greece.

Chavit Tunvirachaisakul (C)

Chulalongkorn University, Department of Psychiatry, Thailand.

Michael Maes (M)

Chulalongkorn University, Department of Psychiatry, Thailand.

Teerayuth Rungnirundorn (T)

Chulalongkorn University, Department of Psychiatry, Thailand.

Thitiporn Supasitthumrong (T)

Chulalongkorn University, Department of Psychiatry, Thailand.

Ariful Haque (A)

The National Foundation of Mental Health of Bangladesh, Bangladesh.

Andre R Brunoni (AR)

Faculdade de Medicina da Universidade de São Paulo, Departments of Internal Medicine and Psychiatry, São Paulo, Brazil; Instituto de Psiquiatria do Hospital das Clínicas da FMUSP, Brazil.

Carlos Gustavo Costardi (CG)

Universidade Federal de São Paulo, Department of Psychiatry, São Paulo, Brazil.

Felipe Barreto Schuch (FB)

Universidade Federal de Santa Maria, Department of Sports Methods and Techniques, Santa Maria, RS, Brazil; Faculty of Health Sciences, Universidad Autónoma de Chile, Providencia, Chile; Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Guilherme Polanczyk (G)

Faculdade de Medicina da Universidade de São Paulo, Departments of Internal Medicine and Psychiatry, São Paulo, Brazil.

Jhoanne Merlyn Luiz (JM)

Universidade do Extremo Sul Catarinense, Translational Psychiatry Laboratory, Graduate Program in Health Sciences, Criciúma, SC, Brazil.

Lais Fonseca (L)

Universidade Federal de São Paulo, Department of Psychiatry, São Paulo, Brazil.

Luana V Aparicio (LV)

Faculdade de Medicina da Universidade de São Paulo, Departments of Internal Medicine and Psychiatry, São Paulo, Brazil.

Samira S Valvassori (SS)

Universidade do Extremo Sul Catarinense, Translational Psychiatry Laboratory, Graduate Program in Health Sciences, Criciúma, SC, Brazil.

Merete Nordentoft (M)

University of Copenhagen, Copenhagen, Denmark.

Per Vendsborg (P)

Psykiatrifonden, Copenhagen, Denmark.

Sofie Have Hoffmann (SH)

National Institute of Public Health, University of Southern Denmark, Denmark.

Jihed Sehli (J)

Le Jolimont Psychiatry and Psychotherapy, Fribourg, Switzerland.

Norman Sartorius (N)

Association for the Improvement of Mental Health Programmes (AMH), Switzerland.

Sabina Heuss (S)

FHNW University of Applied Sciences and Arts Northwestern Switzerland, Switzerland.

Daniel Guinart (D)

Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, USA; Institut de Salut Mental, Parc de Salut Mar, Barcelona, Spain; Hospital del Mar Research Institute, CIBERSAM, Barcelona, Spain.

Jane Hamilton (J)

University of Texas Health Science Center Houston, McGovern Medical School, Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, USA.

John Kane (J)

The Zucker Hillside Hospital, Northwell Health, New York, USA; Feinstein Institutes for Medical Research, Center for Psychiatric Neuroscience, Manhasset, New York, USA.

Jose Rubio (J)

The Zucker Hillside Hospital, Northwell Health, New York, USA; Feinstein Institutes for Medical Research, Center for Psychiatric Neuroscience, Manhasset, New York, USA.

Michael Sand (M)

S2 Consulting LLC.

Ai Koyanagi (A)

Parc Sanitari Sant Joan de Deu, Barcelona, Spain.

Aleix Solanes (A)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Imaging of Mood- and Anxiety-Related Disorders (IMARD), University of Barcelona, CIBERSAM, Instituto de Salud Carlos III, Barcelona, Spain.

Alvaro Andreu-Bernabeu (A)

Hospital General Universitario Gregorio Marañón, Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health (IPS MARAÑÓN), IiSGM, CIBERSAM, Universidad Complutense, Madrid, Spain.

Antonia San José Cáceres (ASJ)

Hospital General Universitario Gregorio Marañón, Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health (IPS MARAÑÓN), IiSGM, CIBERSAM, Universidad Complutense, Madrid, Spain.

Celso Arango (C)

Hospital General Universitario Gregorio Marañón, Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health (IPS MARAÑÓN), IiSGM, CIBERSAM, Universidad Complutense, Madrid, Spain.

Covadonga M Díaz-Caneja (CM)

Hospital General Universitario Gregorio Marañón, Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health (IPS MARAÑÓN), IiSGM, CIBERSAM, Universidad Complutense, Madrid, Spain.

Diego Hidalgo-Mazzei (D)

University of Barcelona, Hospital Clínic, IDIBAPS, CIBERSAM, Barcelona, Spain.

Eduard Vieta (E)

University of Barcelona, Hospital Clínic, IDIBAPS, CIBERSAM, Barcelona, Spain.

Javier Gonzalez-Peñas (J)

Hospital General Universitario Gregorio Marañón, Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health (IPS MARAÑÓN), IiSGM, CIBERSAM, Universidad Complutense, Madrid, Spain.

Lydia Fortea (L)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Imaging of Mood- and Anxiety-Related Disorders (IMARD), University of Barcelona, CIBERSAM, Instituto de Salud Carlos III, Barcelona, Spain.

Mara Parellada (M)

Hospital General Universitario Gregorio Marañón, Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health (IPS MARAÑÓN), IiSGM, CIBERSAM, Universidad Complutense, Madrid, Spain.

Miquel A Fullana (MA)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Imaging of Mood- and Anxiety-Related Disorders (IMARD), University of Barcelona, CIBERSAM, Instituto de Salud Carlos III, Barcelona, Spain.

Norma Verdolini (N)

University of Barcelona, Hospital Clínic, IDIBAPS, CIBERSAM, Barcelona, Spain; Local Health Unit 1, Department of Mental Health, Mental Health Center of Perugia, Italy.

Eva Andrlíková (E)

National Institute of Mental Health, Klecany, Czech Republic.

Karolina Janků (K)

National Institute of Mental Health, Klecany, Czech Republic.

Mark J Millan (MJ)

Glasgow University, Institute of Neuroscience and Psychology, College of Medicine, Vet and Life Science, Glasgow, United Kingdom.

Mihaela Honciuc (M)

Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Psychiatrie B, Clermont-Ferrand, France.

Anna Moniuszko-Malinowska (A)

Medical University of Białystok, Department of Infectious Diseases and Neuroinfections, Poland.

Igor Łoniewski (I)

Pomeranian Medical University in Szczecin, Department of Biochemical Sciences, Szczecin, Poland; Sanprobi Sp. z o.o. Sp. k, Poland.

Jerzy Samochowiec (J)

Pomeranian Medical University in Szczecin, Department of Psychiatry, Szczecin, Poland.

Łukasz Kiszkiel (Ł)

University of Białystok, Institute of Sociology, Society and Cognition Unit, Białystok, Poland.

Maria Marlicz (M)

Pomeranian Medical University in Szczecin, Department of Biochemical Sciences, Szczecin, Poland.

Paweł Sowa (P)

Medical University of Białystok, Department of Population Medicine and Lifestyle Diseases Prevention, Bialystok, Poland.

Wojciech Marlicz (W)

Pomeranian Medical University in Szczecin, Department of Gastroenterology, Szczecin, Poland; The Centre for Digestive Diseases Endoklinika, Szczecin, Poland.

Georgina Spies (G)

South African Medical Research Council Unit on the Genomics of Brain Disorders, Stellenbosch University, Department of Psychiatry, Faculty of Medicine and Health Sciences, South Africa.

Brendon Stubbs (B)

King's College London, London, United Kingdom.

Joseph Firth (J)

University of Manchester, Division of Psychology and Mental Health, Manchester, United Kingdom.

Sarah Sullivan (S)

Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Asli Enez Darcin (AE)

Istanbul Topkapı University, Istanbul, Turkey.

Hatice Aksu (H)

Adnan Menderes University Department of Child and Adolescent Psychiatry, Aydın, Turkey.

Nesrin Dilbaz (N)

Uskudar University, Department of Psychiatry and Psychology, Istanbul, Turkey.

Onur Noyan (O)

Uskudar University, Department of Psychiatry and Psychology, Istanbul, Turkey.

Momoko Kitazawa (M)

Keio University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan.

Shunya Kurokawa (S)

Keio University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan.

Yuki Tazawa (Y)

Keio University School of Medicine, Department of Neuropsychiatry, Tokyo, Japan.

Alejandro Anselmi (A)

Department of Psychology, Universidad Católica del Uruguay.

Cecilia Cracco (C)

Department of Psychology, Universidad Católica del Uruguay.

Ana Inés Machado (AI)

Department of Psychology, Universidad Católica del Uruguay.

Natalia Estrade (N)

Department of Psychology, Universidad Católica del Uruguay.

Diego De Leo (D)

Griffith University, South East Queensland, Australia.

Jackie Curtis (J)

Mindgardens Neuroscience Network, Sydney, Australia.

Michael Berk (M)

Deakin University School of Medicine, Victoria, Australia.

Andre F Carvalho (AF)

Deakin University School of Medicine, Victoria, Australia.

Philip Ward (P)

UNSW Sydney, School of Psychiatry, Sydney, Australia.

Scott Teasdale (S)

UNSW Sydney, School of Psychiatry, Sydney, Australia.

Simon Rosenbaum (S)

UNSW Sydney, School of Psychiatry, Sydney, Australia.

Wolfgang Marx (W)

Deakin University School of Medicine, Victoria, Australia.

Adrian Vasile Horodnic (AV)

University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Iasi, Romania.

Liviu Oprea (L)

University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Iasi, Romania.

Ovidiu Alexinschi (O)

Institute of Psychiatry "Socola", Iasi, Romania.

Petru Ifteni (P)

Transilvania University of Brasov, Faculty of Medicine, Brasov, Romania.

Serban Turliuc (S)

University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Iasi, Romania.

Tudor Ciuhodaru (T)

Emergency Hospital "Nicolae Oblu", Iasi, Romania.

Alexandra Bolos (A)

University of Medicine and Pharmacy Grigore T. Popa, Faculty of Medicine, Iasi, Romania.

Valentin Matei (V)

Psychiatry Department, University of Medicine and Pharmacy "Carol Davila" Bucharest, "Prof. Dr. Alexandru Obregia" Psychiatric Hospital, Bucharest, Romania.

Dorien H Nieman (DH)

Amsterdam University Medical Centers (location AMC), Department of Psychiatry, Amsterdam, the Netherlands.

Iris Sommer (I)

University Medical Center Groningen, Antoni Deusinglaan 2, room 117, Groningen, the Netherlands.

Jim van Os (J)

Utrecht University Medical Centre, Department of Psychiatry, Utrecht, the Netherlands.

Therese van Amelsvoort (T)

Maastricht University, Department of Psychiatry and Neuropsychology, Maastricht, the Netherlands.

Ching-Fang Sun (CF)

China Medical University Hospital, Mind-Body Interface Research Center, Taichung, Taiwan; Department of Psychiatry and Behavioral Medicine, Carilion Clinic Virginia Tech Carilion School of Medicine, Roanoke, VA, USA.

Ta-Wei Guu (TW)

China Medical University Hospital, Mind-Body Interface Research Center, Taichung, Taiwan; King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom; China Medical University Beigang Hospital, Division of Psychiatry, Department of Internal Medicine, Taiwan.

Can Jiao (C)

Shenzhen University, School of Psychology, Shenzhen, China.

Jieting Zhang (J)

Shenzhen University, School of Psychology, Shenzhen, China.

Jialin Fan (J)

Shenzhen University, School of Psychology, Shenzhen, China.

Liye Zou (L)

Shenzhen University, School of Psychology, Shenzhen, China.

Xin Yu (X)

Peking University Institute of Mental Health, Department of Public Mental Health, Pekin, China.

Xinli Chi (X)

Shenzhen University, School of Psychology, Shenzhen, China.

Philippe de Timary (P)

UCLouvain, Institute of Neuroscience and Cliniques Universitaires Saint-Luc, Department of Adult Psychiatry, Brussels, Belgium; Cliniques Universitaires Saint-Luc, Department of Adult Psychiatry, Brussels, Belgium.

Ruud van Winkel (R)

Katholieke Universiteit Leuven (KU Leuven), Department of Neurosciences, Leuven, Belgium.

Bernardo Ng (B)

Asociación Psiquiátrica Mexicana, Mexico.

Edilberto Peña de León (E)

Asociación Psiquiátrica Mexicana, Mexico.

Ramon Arellano (R)

Asociación Psiquiátrica Mexicana, Mexico.

Raquel Roman (R)

Asociación Psiquiátrica Mexicana, Mexico.

Thelma Sanchez (T)

Asociación Psiquiátrica Mexicana, Mexico.

Larisa Movina (L)

Moscow Research Institute of Psychiatry, Moscow, Russia.

Pedro Morgado (P)

University of Minho, Life and Health Sciences Research Institute (ICVS), School of Medicine, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.

Sofia Brissos (S)

Lisbon's Psychiatric Hospital Centre, Department of Psychiatry, Portugal.

Oleg Aizberg (O)

Belarusian Medical Academy of Postgraduate Education, Belarus.

Anna Mosina (A)

Clienia AG, Wetzikon Psychiatric Centre, Switzerland.

Damir Krinitski (D)

Integrated Psychiatry Winterthur (IPW), Switzerland.

James Mugisha (J)

Kyambogo University, Department of Sociology and Social Administration, Kampala, Uganda.

Dena Sadeghi-Bahmani (D)

Stanford University, Department of Psychology, California, USA; Universitäre Psychiatrische Kliniken Basel (UPK), Center of Affective, Stress and Sleep Disorders (ZASS), Basel, Switzerland.

Farshad Sheybani (F)

Department of Psychiatry and Clinical Psychology, Mashhad University of Medical Sciences, Mashhad, Iran.

Masoud Sadeghi (M)

Kermanshah University of Medical Sciences, Medical Biology Research Center, Kermanshah, Iran.

Samira Hadi (S)

Kharazmi University, Tehran, Iran.

Serge Brand (S)

Universitäre Psychiatrische Kliniken Basel (UPK), Center of Affective, Stress and Sleep Disorders (ZASS), Basel, Switzerland; University of Basel, Department of Sport, Exercise, and Health, Division of Sport Science and Psychosocial Health, Basel, Switzerland; Kermanshah University of Medical Sciences, Substance Abuse Prevention Research Center, Kermanshah, Iran; Kermanshah University of Medical Sciences, Sleep Disorders Research Center, Kermanshah, Iran; Tehran University of Medical Sciences, School of Medicine, Tehran, Iran; Center for Disaster Psychiatry and Disaster Psychology, Psychiatric Clinics of the University of Basel, Basel, Switzerland.

Antonia Errazuriz (A)

Pontificia Universidad Católica de Chile, Department of Psychiatry, School of Medicine, Santiago, Chile.

Nicolas Crossley (N)

Pontificia Universidad Católica de Chile, Department of Psychiatry, School of Medicine, Santiago, Chile.

Dragana Ignjatovic Ristic (DI)

University of Kragujevac, Department of Psychiatry, Faculty of Medical Sciences, Kragujevac, Serbia.

Carlos López-Jaramillo (C)

University of Antioquia, Department of Psychiatry, Medellín, Colombia.

Dimitris Efthymiou (D)

Nous Therapy Center, 1st Aggelaki str, Thessaloniki 54636, Greece.

Praveenlal Kuttichira (P)

Jubilee Mission Medical College & Research Institute, Thrissur, India.

Roy Abraham Kallivayalil (RA)

Pushpagiri Institute of Medical Sciences, Department of Psychiatry, Thiruvalla, Kerala, India.

Afzal Javed (A)

Chairman, Pakistan Psychiatric Research Centre-Fountain House, Lahore, Pakistan.

Muhammad Iqbal Afridi (MI)

Distinguished National Professor, Jinnah Sindh Medical University, Karachi, Pakistan; Adjunct Professor of Psychiatry, Baylor College of Medicine, Texas, USA.

Bawo James (B)

Tees Esk & Wear Valleys NHS Foundation Trust, UK.

Omonefe Joy Seb-Akahomen (OJ)

Irrua Specialist Teaching Hospital, Department of Psychiatry, Edo State, Nigeria.

Jess Fiedorowicz (J)

University of Ottawa, Department of Psychiatry, Ontario, Canada; The Ottawa Hospital, Department of Mental Health, Ontario, Canada; Ottawa Hospital Research Institute (OHRI) Neurosciences Program, Ottawa Ontario, Canada.

Jeff Daskalakis (J)

University of California San Diego, California, United States.

Lakshmi N Yatham (LN)

University of British Columbia, Vancouver, Canada.

Lin Yang (L)

Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, Canada; Departments of Oncology and Community Health Sciences, University of Calgary, Calgary, Canada.

Tarek Okasha (T)

Okasha Institute of Psychiatry, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Aïcha Dahdouh (A)

Oran 1 University, Department of Psychiatry-Addictology, Oran, Algeria.

Jari Tiihonen (J)

Karolinska Institutet, Centre for Psychiatric Research and Education, Department of Clinical Neuroscience, Stockholm, Sweden; University of Eastern Finland, Department of Forensic Psychiatry, Niuvanniemi Hospital, Kuopio, Finland.

Jae Il Shin (JI)

Yonsei University College of Medicine, Department of Pediatrics, Seoul, South Korea.

Jinhee Lee (J)

Yonsei University, Wonju College of Medicine, Department of Psychiatry, Wonju, South Korea.

Ahmed Mhalla (A)

University of Monastir, Faculty of Medicine of Monastir, Research Unit "Vulnerability to Mental Disorders" LR05ES10, Monastir, Tunisia.

Lotfi Gaha (L)

University of Monastir, Faculty of Medicine of Monastir, Research Unit "Vulnerability to Mental Disorders" LR05ES10, Monastir, Tunisia.

Takoua Brahim (T)

University of Monastir, Faculty of Medicine of Monastir, Research Unit "Vulnerability to Mental Disorders" LR05ES10, Monastir, Tunisia.

Kuanysh Altynbekov (K)

Republican Scientific and Practical Center of Mental Health, Almaty, Kazakhstan.

Nikolay Negay (N)

Republican Scientific and Practical Center of Mental Health, Almaty, Kazakhstan.

Saltanat Nurmagambetova (S)

Republican Scientific and Practical Center of Mental Health, Almaty, Kazakhstan.

Yasser Abu Jamei (YA)

Gaza Community Mental Health Programme, Gaza, Palestine.

Mark Weiser (M)

Sheba Medical Center, Israel.

Christoph U Correll (CU)

Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, USA; The Zucker Hillside Hospital, Northwell Health, New York, USA; Feinstein Institutes for Medical Research, Center for Psychiatric Neuroscience, Manhasset, New York, USA. Electronic address: christoph.correll@charite.de.

Classifications MeSH